COMPANY PROFILE // THE 014 REPORT
Idexx Laboratories Inc. /De
IDXX (Nasdaq)
Assembled from 4 government sources in 0.3 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber3 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-03-26: a pattern of leadership change.
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
IDEXX LABORATORIES INC /DE is an SEC-registered operating company in in vitro & in vivo diagnostic substances, incorporated in DE, based in Westbrook, ME; listed as IDXX (Nasdaq).[source] It reported revenue of $4.30 billion for the fiscal year ended 2025-12-31.[source] It has filed 81 documents with the SEC in the last 12 months; the latest is Form 4, filed 2026-11-20.[source] Its largest institutional holders on 13F filings are BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD PORTFOLIO MANAGEMENT LLC (as of 2026-06-30).[source] Seraphix flags 1 item from these records: 3 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-03-26.[source]
- red0
- amber1
- info0
- BlackRock, Inc.$4.30B
- VANGUARD CAPITAL MANAGEMENT LLC$2.71B
- VANGUARD PORTFOLIO MANAGEMENT LLC$2.05B
- STATE STREET CORP$1.97B
- Invesco Ltd.$1.90B
- GEODE CAPITAL MANAGEMENT, LLC$1.35B
- BAMCO INC /NY/$1.04B
- Bank of New York Mellon Corp$628.2M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions. (Wikipedia, CC BY-SA 4.0)
Officers and directors (Forms 3, 4, 5)
- Emerson Andrew · EVP, CFO and Treasurer (Officer) · latest Form 4 2026-02-17 · filing · LinkedIn search
- Erickson Michael G · Executive Vice President (Officer) · latest Form 4/A 2026-03-03 · filing · LinkedIn search
- FENNELL GEORGE · Executive Vice President (Officer) · latest Form 4 2026-02-17 · filing · LinkedIn search
- Hunt Nimrata · Executive Vice President (Officer) · latest Form 4 2026-03-05 · filing · LinkedIn search
- Johnson Michael Perkins · Executive Vice President (Officer) · latest Form 4 2026-02-17 · filing · LinkedIn search
- Lane Michael · Executive Vice President (Officer) · latest Form 4 2026-02-17 · filing · LinkedIn search
- MAZELSKY JONATHAN JAY · President and CEO (Director,Officer) · latest Form 4 2026-03-02 · filing · LinkedIn search
- Schreck Michael · Executive Vice President (Officer) · latest Form 4 2026-02-17 · filing · LinkedIn search
- Smith Martin Alexander · Executive Vice President (Officer) · latest Form 4 2026-02-17 · filing · LinkedIn search
- Underberg Sharon E. · EVP, GC & Corporate Secretary (Officer) · latest Form 4 2026-03-05 · filing · LinkedIn search
- Britt Irene Chang · Director · latest Form 4 2025-05-08 · filing · LinkedIn search
- Claflin Bruce L. · Director · latest Form 4 2025-05-08 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Pierce Atwood LLP · Exhibit 5.1 legal opinion, S-8 POS filed 2018-07-19
Links
- Official website (Wikidata or the SEC record)
- Wikipedia
- Wikidata
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0000874716 | source |
| EIN | 01-0393723 | source |
| Business address (SEC) | ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-01 · in 99 days · Next 10-K due (period ended 2026-12-31; Large accelerated filer) (computed from the fiscal year end and filer status)
- 2027-05-10 · in 169 days · Next 10-Q due (period ended 2027-03-31; Large accelerated filer) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2835 (in vitro & in vivo diagnostic substances): 21 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- Lantheus Holdings, Inc. · 84 SEC filings in 12 months · 1 flag · $156.2M federal (possible match)
- NEOGEN CORP · 77 SEC filings in 12 months · 3 flags · $3.0M federal (possible match)
- ACHIEVE LIFE SCIENCES, INC. · 75 SEC filings in 12 months · 2 flags · $2.5M federal (possible match)
- TRINITY BIOTECH PLC · 78 SEC filings in 12 months · 1 flag · $422K federal (possible match)
- QuidelOrtho Corp · 105 SEC filings in 12 months · 2 flags · $20K federal (possible match)
- Alpha Teknova, Inc. · 22 SEC filings in 12 months · $15K federal (possible match)
- VOLITIONRX LTD · 95 SEC filings in 12 months · 2 flags
- IDEXX LABORATORIES INC /DE · 80 SEC filings in 12 months · 1 flag
- Intellia Therapeutics, Inc. · 73 SEC filings in 12 months · 2 flags
- IMMUCELL CORP /DE/ · 48 SEC filings in 12 months · 1 flag
- Aspira Women's Health Inc. · 46 SEC filings in 12 months · 6 flags
- Virax Biolabs Group Ltd · 41 SEC filings in 12 months
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- Aptiv PLC · HOOLEY JOSEPH L
- CIENA CORP · Claflin Bruce L.
- DENTSPLY SIRONA Inc. · MAZELSKY JONATHAN JAY
- Dropbox, Inc. · Peacock Karen
- EXXON MOBIL CORP · HOOLEY JOSEPH L
- First Watch Restaurant Group, Inc. · Britt Irene Chang
- INSULET CORP · MAZELSKY JONATHAN JAY
- INTEGRA LIFESCIENCES HOLDINGS CORP · ESSIG STUART
- Mirion Technologies, Inc. · Kingsley Lawrence D
- PIPER SANDLER COMPANIES · ESSIG STUART
- Polaris Inc. · Kingsley Lawrence D
- QUEST DIAGNOSTICS INC · SAMAD SAM
- REVVITY, INC. · Vandebroek Sophie V.
- Victoria's Secret & Co. · Britt Irene Chang
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-05 filing 144/A · SEC EDGAR
- 2026-11-04 filing 144 · SEC EDGAR
- 2026-11-04 filing 144 · SEC EDGAR
- 2026-11-04 filing 144 · SEC EDGAR
- 2026-11-04 filing 144 · SEC EDGAR
- 2026-11-02 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-02 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-09-04 filing 144 · SEC EDGAR
- 2026-08-04 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-04 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-06-01 filing SD · SEC EDGAR
- 2026-05-20 filing 144 · SEC EDGAR
- 2026-05-15 filing 8-K items 5.03,5.07,9.01 · SEC EDGAR
- 2026-05-05 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-05 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-03-27 filing ARS · SEC EDGAR
- 2026-03-27 filing DEFA14A · SEC EDGAR
- 2026-03-27 filing Proxy statement · SEC EDGAR
- 2026-03-26 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-03-13 filing PRE 14A · SEC EDGAR
- 2026-03-03 filing 144 · SEC EDGAR
- 2026-02-26 filing 144 · SEC EDGAR
- 2026-02-25 filing 144 · SEC EDGAR
- 2026-02-20 filing Annual report (10-K) · SEC EDGAR
- 2026-02-17 filing 144 · SEC EDGAR
- 2026-02-17 filing 144 · SEC EDGAR
- 2026-02-17 insider First Form 3/4/5 on record for Schreck Michael (Executive Vice President) · SEC Forms 3/4/5
- 2026-02-13 officer change 8-K items 5.02 · SEC EDGAR
- 2026-02-11 insider First Form 3/4/5 on record for FENNELL GEORGE (Executive Vice President) · SEC Forms 3/4/5
- 2026-02-10 filing 144 · SEC EDGAR
128 earlier entries
- 2026-02-02 filing 8-K items 2.02,9.01
- 2026-01-13 officer change 8-K items 5.02,7.01,9.01
- 2025-11-13 filing 8-K items 1.01,2.03,9.01
- 2025-11-07 filing 144
- 2025-11-03 filing Quarterly report (10-Q)
- 2025-11-03 filing 8-K items 2.02,9.01
- 2025-10-20 filing 3/A
- 2025-10-14 insider First Form 3/4/5 on record for Peacock Karen (Director)
- 2025-10-07 officer change 8-K items 5.02,9.01
- 2025-09-03 insider First Form 3/4/5 on record for Smith Martin Alexander (Executive Vice President)
- 2025-08-22 filing 144
- 2025-08-14 filing 5/A
- 2025-08-14 filing 3/A
- 2025-08-14 insider First Form 3/4/5 on record for Erickson Michael G (Executive Vice President)
- 2025-08-12 filing 144
- 2025-08-12 insider First Form 3/4/5 on record for Underberg Sharon E. (EVP, GC & Corporate Secretary)
- 2025-08-11 filing 144
- 2025-08-11 insider First Form 3/4/5 on record for Emerson Andrew (EVP, CFO and Treasurer)
- 2025-08-08 filing 144
- 2025-08-08 insider First Form 3/4/5 on record for Hunt Nimrata (Executive Vice President)
- 2025-08-08 insider First Form 3/4/5 on record for Lane Michael (Executive Vice President)
- 2025-08-08 insider First Form 3/4/5 on record for MAZELSKY JONATHAN JAY (President and CEO)
- 2025-08-06 filing 144
- 2025-08-06 filing 144
- 2025-08-06 filing 144
- 2025-08-04 filing Quarterly report (10-Q)
- 2025-08-04 filing 8-K items 2.02,9.01
- 2025-07-18 insider First Form 3/4/5 on record for HOOLEY JOSEPH L (Director)
- 2025-07-10 officer change 8-K items 5.02,9.01
- 2025-07-07 filing UPLOAD
- 2025-06-03 insider First Form 3/4/5 on record for Johnson Michael Perkins (Executive Vice President)
- 2025-06-02 filing CORRESP
- 2025-05-30 filing SD
- 2025-05-21 filing 144
- 2025-05-21 filing UPLOAD
- 2025-05-13 filing 144
- 2025-05-09 filing 144
- 2025-05-09 filing 8-K items 5.03,5.07,9.01
- 2025-05-08 insider First Form 3/4/5 on record for Britt Irene Chang (Director)
- 2025-05-08 insider First Form 3/4/5 on record for Claflin Bruce L. (Director)
- 2025-05-08 insider First Form 3/4/5 on record for ESSIG STUART (Director)
- 2025-05-08 insider First Form 3/4/5 on record for JUNIUS DANIEL M (Director)
- 2025-05-08 insider First Form 3/4/5 on record for Kingsley Lawrence D (Director)
- 2025-05-08 insider First Form 3/4/5 on record for SAMAD SAM (Director)
- 2025-05-08 insider First Form 3/4/5 on record for SZOSTAK M ANNE (Director)
- 2025-05-08 insider First Form 3/4/5 on record for Vandebroek Sophie V. (Director)
- 2025-05-02 filing 144
- 2025-05-01 filing Quarterly report (10-Q)
- 2025-05-01 filing 8-K items 2.02,9.01
- 2025-04-30 filing CORRESP
- 2025-04-24 filing UPLOAD
- 2025-03-28 filing ARS
- 2025-03-28 filing DEFA14A
- 2025-03-28 filing Proxy statement
- 2025-03-14 filing PRE 14A
- 2025-02-21 filing Annual report (10-K)
- 2025-02-14 officer change 8-K items 5.02
- 2025-02-10 filing 144
- 2025-02-07 filing 144
- 2025-02-03 filing 8-K items 2.02,9.01
- 2024-12-12 officer change 8-K items 5.02
- 2024-12-09 filing 8-K items 8.01,9.01
- 2024-11-27 filing 144
- 2024-11-21 officer change 8-K items 5.02,7.01,9.01
- 2024-11-12 officer change 8-K items 5.02,9.01
- 2024-11-06 filing 8-K items 1.01
- 2024-10-31 filing Quarterly report (10-Q)
- 2024-10-31 filing 8-K/A items 2.02,9.01
- 2024-10-31 filing 8-K items 2.02,9.01
- 2024-09-06 filing 144
- 2024-08-06 filing Quarterly report (10-Q)
- 2024-08-06 filing 8-K items 2.02,9.01
- 2024-05-31 filing SD
- 2024-05-17 filing 144
- 2024-05-10 officer change 8-K items 5.02,5.07,9.01
- 2024-05-01 filing Quarterly report (10-Q)
- 2024-05-01 filing 8-K items 2.02,9.01
- 2024-03-27 filing ARS
- 2024-03-27 filing DEFA14A
- 2024-03-27 filing Proxy statement
- 2024-03-06 filing 144
- 2024-03-05 filing 144
- 2024-02-22 filing Annual report (10-K)
- 2024-02-08 filing 144
- 2024-02-07 filing 144
- 2024-02-07 filing 144
- 2024-02-05 filing 8-K items 2.02,9.01
- 2023-12-07 filing 144
- 2023-12-07 officer change 8-K items 5.02
- 2023-12-04 filing 144
- 2023-11-01 filing Quarterly report (10-Q)
- 2023-11-01 filing 8-K items 2.02,9.01
- 2023-08-31 filing 144
- 2023-08-29 filing 144
- 2023-08-03 filing 144
- 2023-08-01 filing Quarterly report (10-Q)
- 2023-08-01 filing 8-K items 2.02,9.01
- 2023-07-12 officer change 8-K items 5.02,9.01
- 2023-05-31 filing SD
- 2023-05-19 filing 144
- 2023-05-19 filing 8-K items 5.07
- 2023-05-18 filing 144
- 2023-05-16 filing 144
- 2023-05-10 filing 144
- 2023-05-05 filing 144
- 2023-05-05 filing 144
- 2023-05-04 filing 144
- 2023-05-02 filing Quarterly report (10-Q)
- 2023-05-02 filing 8-K items 2.02,9.01
- 2023-03-31 filing ARS
- 2023-03-31 filing DEFA14A
- 2023-03-31 filing Proxy statement
- 2023-02-16 filing Annual report (10-K)
- 2023-02-06 filing 8-K items 2.02,9.01
- 2022-11-01 filing Quarterly report (10-Q)
- 2022-11-01 filing 8-K items 2.02,9.01
- 2022-10-21 filing 8-K items 1.01,2.03,9.01
- 2022-08-02 filing Quarterly report (10-Q)
- 2022-08-02 filing 8-K items 2.02,9.01
- 2022-07-15 filing 8-K items 5.03,9.01
- 2022-06-14 filing 8-K items 7.01
- 2022-05-31 filing SD
- 2022-05-13 filing 8-K items 5.07
- 2022-05-04 filing Quarterly report (10-Q)
- 2022-05-04 filing 8-K items 2.02,9.01
- 2022-03-31 filing DEFA14A
- 2022-03-31 filing Proxy statement
- 2022-02-16 filing Annual report (10-K)
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-02 (within 30 days) 10-Q filed
- 2026-11-02 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-09-28 (older) Form 5500 received for plan year ending 2025-12-31 (plan no. 001)
- 2026-08-04 (older) 10-Q filed
- 2026-08-04 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-28 (older) Form 5500 received for plan year ending 2025-12-31 (plan no. 504)
- 2026-06-15 (older) latest certified decision date in the file
- 2026-06-01 (older) SD filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:IDXX The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 874716 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | IDXX / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 010393723 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000874716 | SEC EDGAR / IRS |
| CUSIP | 45168D104 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000874716 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $4,303,702,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-22 05:03 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $1,059,464,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-22 05:03 UTC | Report an error |
| Total assets (at 2025-12-31) | $3,350,759,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-22 05:03 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $1,605,383,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-22 05:03 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $180,070,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-22 05:03 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
| SIC industry | 2835 In Vitro & In Vivo Diagnostic Substances | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
| State of incorporation | DE | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
| Business address | ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041 | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-22 05:03 UTC | Report an error |
Other filed values
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-02 · accession 0000874716-26-000135
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $1,214,237,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-02 | 0000874716-26-000135 | 2026-11-22 05:03 UTC | Report an error |
| Net income (loss) | $317,145,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-02 | 0000874716-26-000135 | 2026-11-22 05:03 UTC | Report an error |
| Interest expense | $7,459,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-02 | 0000874716-26-000135 | 2026-11-22 05:03 UTC | Report an error |
| Cash and cash equivalents | $197,536,000 | at 2026-09-30 | 10-Q | 2026-11-02 | 0000874716-26-000135 | 2026-11-22 05:03 UTC | Report an error |
| Contract liabilities, current | $40,181,000 | at 2026-09-30 | 10-Q | 2026-11-02 | 0000874716-26-000135 | 2026-11-22 05:03 UTC | Report an error |
| Contract liabilities, noncurrent | $32,709,000 | at 2026-09-30 | 10-Q | 2026-11-02 | 0000874716-26-000135 | 2026-11-22 05:03 UTC | Report an error |
| Debt due in the next 12 months (from an earlier report) | $75,000,000 | at 2025-12-31 | 10-K | 2026-02-20 | 0000874716-26-000038 | 2026-11-22 05:03 UTC | Report an error |
| Debt due in year 2 (from an earlier report) | $75,000,000 | at 2025-12-31 | 10-K | 2026-02-20 | 0000874716-26-000038 | 2026-11-22 05:03 UTC | Report an error |
| Debt due in year 3 (from an earlier report) | $0 | at 2025-12-31 | 10-K | 2026-02-20 | 0000874716-26-000038 | 2026-11-22 05:03 UTC | Report an error |
| Debt due in year 4 (from an earlier report) | $100,000,000 | at 2025-12-31 | 10-K | 2026-02-20 | 0000874716-26-000038 | 2026-11-22 05:03 UTC | Report an error |
| Debt due in year 5 (from an earlier report) | $200,000,000 | at 2025-12-31 | 10-K | 2026-02-20 | 0000874716-26-000038 | 2026-11-22 05:03 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-02 Filing 10-Q filed
- 2026-11-02 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-09-28 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 001)
- 2026-08-04 Filing 10-Q filed
- 2026-08-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-28 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 504)
- 2026-06-15 Record latest certified decision date in the file
- 2026-06-01 Filing SD filed
- 2026-05-15 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-05-05 Filing 10-Q filed
- 2026-05-05 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-02 Record earliest certified decision date in the file
- 2026-03-27 Filing ARS filed
- 2026-03-27 Filing DEFA14A filed
- 2026-03-27 Filing DEF 14A filed
- 2026-03-26 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-03-13 Filing PRE 14A filed
- 2026-02-20 Filing 10-K filed
- 2026-02-13 Filing 8-K filed: Item 5.02 officer or director change
- 2026-02-02 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-01-13 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-11-13 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 9.01 exhibits
- 2025-11-03 Filing 10-Q filed
- 2025-11-03 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-10-07 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
6 earlier entries
- 2025-08-04 Filing 10-Q filed
- 2025-08-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-07-10 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2025-07-07 Filing UPLOAD filed
- 2013-01-01 Record plan effective date: IDEXX LABORATORIES, INC. EMPLOYEE WELFARE BENEFIT PLAN
- 1990-01-01 Record plan effective date: IDEXX RETIREMENT AND INCENTIVE SAVINGS PLAN
8-K item text, as filed (excerpts)
- 2026-11-02 8-K Item 2.02, Results of Operations and Financial Condition
On November 2, 2026, IDEXX Laboratories, Inc. (the “Company”) announced its financial results for the quarter ended September 30, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with general instructions to Form 8-K, the information in this Form 8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities… the 8-K · retrieved 2026-11-22 05:03 UTC - 2026-08-04 8-K Item 2.02, Results of Operations and Financial Condition
On August 4, 2026, IDEXX Laboratories, Inc. (the “Company”) announced its financial results for the quarter ended June 30, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with general instructions to Form 8-K, the information in this Form 8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of… the 8-K · retrieved 2026-11-22 05:03 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $4,301,108,318 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $2,712,331,011 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | $2,051,284,515 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
| 4 | STATE STREET CORP | $1,973,444,570 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
| 5 | Invesco Ltd. | $1,901,193,880 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $1,345,877,922 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
| 7 | BAMCO INC /NY/ | $1,040,655,010 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
| 8 | Bank of New York Mellon Corp | $628,223,174 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $561,752,542 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
| 10 | Fundsmith LLP | $536,909,312 | 2026-06-30 | SEC 13F filing | 2026-11-22 05:03 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
DOL H-1B (LCA) · WARN NOT HELD12. Labor
Unconfirmed: these labor figures (positions, worksite states, certified LCAs later withdrawn) are as read from DOL's quarterly LCA disclosure file. Seraphix's independent second check of them is not finished (11-19); they are shown as filed, not as verified.
WARN layoff notices: not held yet.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/874716.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0000874716. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.